Basel
Switzerland
7
2021-06-17
7
2022-04-19
These are the the leading inventors for applications assigned to Axovant Sciences GmbH:
Axovant Sciences GmbH based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HTserotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
#2 | 2018-05-17 ✅ Patent 10,370,370 granted on 2019-08-06Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors
#3 | 2017-12-28 ✅ Patent 10,183,938 granted on 2019-01-22Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors
#4 | 2017-02-16 ✅ Patent 10,428,062 granted on 2019-10-01Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors
#5 | 2017-01-19 ✅ Patent 10,034,859 granted on 2018-07-31Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
#6 | 2016-12-15 ✅ Patent 10,022,355 granted on 2018-07-17Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
#7 | 2015-11-12 ✅ Patent 9,808,455 granted on 2017-11-07Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
Also check out Axovant Sciences GmbH's (Basel, Switzerland) applicant profile with 5 patent applications submitted.
376625 ⎘